Study hints at new target to improve immune therapy in triple-negative breast cancer
(University of Colorado Anschutz Medical Campus) University of Colorado Cancer Center study shows that Eya3 may regulate the immune response to a tumor, implying that anti-Eya3 therapies may improve checkpoint inhibitors against triple-negative breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2018 Category: Cancer & Oncology Source Type: news

University of Colorado Cancer Center Study Hints at New Target to...
Eya3 inhibition could be an attractive strategy to increase effectiveness of anti-PD-L1 immunotherapies against triple-negative breast cancer.(PRWeb May 14, 2018)Read the full story at https://www.prweb.com/releases/2018/05/prweb15477653.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 14, 2018 Category: Pharmaceuticals Source Type: news

University of Colorado Cancer Center Study Hints at New Target to...
Eya3 inhibition could be an attractive strategy to increase effectiveness of anti-PD-L1 immunotherapies against triple-negative breast cancer.(PRWeb May 14, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15477653.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 14, 2018 Category: Pharmaceuticals Source Type: news

How Math Can Potentially Reduce Unnecessary Breast Biopsies
The perceived risk of missing a breast cancer diagnosis with imaging studies often leads to unnecessary breast biopsies, according to a new report published in the American Journal of Roentgenology. The authors showed how statistical methods can be used to downgrade the risk classification of breast masses to reduce the need for unnecessary biopsies. Clinicians from San Antonio, TX-based Seno Medical and medical center collaborators from the University of Texas (MD Anderson and U of Texas Health Sciences Center) co-authored the report. The authors studied a statistical calculation known as the negative ...
Source: MDDI - May 11, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Imaging Source Type: news

Breast cancer scare recalls the value of collecting evidence
Research and knowledge are not always enough — people must also notice them (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 11, 2018 Category: Pharmaceuticals Source Type: news

Could a pill outperform mammograms?
Researchers have developed an ingestible pill that causes breast tumors to...Read more on AuntMinnie.comRelated Reading: JAMA: Women need to be aware of mammography's harms How serious is the risk of breast cancer overdiagnosis? Is the mammography debate an example of 'fake science'? Women still value mammography's benefits over 'harms' ACR reaffirms support for annual mammography at 40 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 10, 2018 Category: Radiology Source Type: news

Multigene test increasingly used to assess breast cancer risk
New research suggests women are increasingly foregoing BRCA tests, opting instead for more comprehensive tests that detect mutations in multiple genes. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 10, 2018 Category: Consumer Health News Source Type: news

Zimbabwe:Breast Cancer Victim Seeks Help
[The Herald] A Harare woman who was diagnosed with breast cancer is appealing for financial assistance to buy medication. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 10, 2018 Category: African Health Source Type: news

Medical News Today: Body clock gene may protect against breast cancer
One of the genes that regulate our circadian rhythm might also contribute to the normal development of mammary glands and protect against breast cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 10, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Bioimpedance Spectroscopy Spots Breast Cancer-related Lymphedema Early Bioimpedance Spectroscopy Spots Breast Cancer-related Lymphedema Early
Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - May 9, 2018 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Breast cancer: Working shifts could impact your chances of developing condition
BREAST cancer research has hinted at a possible new cause of the condition. Disrupting the body clock in women may lead to an increased risk of breast cancer, through activities such as late working the night shift. (Source: Daily Express - Health)
Source: Daily Express - Health - May 9, 2018 Category: Consumer Health News Source Type: news

Breast cancer breakthrough: Working shifts could impact your chances of developin
BREAST cancer research has hinted at a possible new cause of the condition. Disrupting the body clock in women may lead to an increased risk of breast cancer, through activities such as late working the night shift. (Source: Daily Express - Health)
Source: Daily Express - Health - May 9, 2018 Category: Consumer Health News Source Type: news

Maryland woman fired after cancer diagnosis awarded $113K
A Maryland woman who was fired weeks after telling her employer she had breast cancer has been awarded more than $100,000 (Source: ABC News: Health)
Source: ABC News: Health - May 9, 2018 Category: Consumer Health News Tags: Health Source Type: news

Lab Study Shows HER2 Inhibitor Lapatinib Can Induce Cell Proliferation
A laboratory study has found that the HER2 inhibitor lapatinib used to slow HER2-positive breast cancer can actually induce tumor growth in some circumstances. (Source: CancerNetwork)
Source: CancerNetwork - May 8, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer HER2-Positive Breast Cancer SiteTerms/www.cannabissciencetech.com/News Source Type: news

Could this new pill replace breast screening?
One in three women who undergo breast cancer treatment did not need to; their benign masses were mistaken as cancerous in scans. A new pill by the University of Michigan hopes to change that. (Source: the Mail online | Health)
Source: the Mail online | Health - May 8, 2018 Category: Consumer Health News Source Type: news

Woman devastated to discover her mother has breast cancer
Amberley Kent, 24, from Peterborough, has had an 'awful' past year after undergoing treatment. But she was 'brought back to square one' when her mother Cathy was diagnosed. (Source: the Mail online | Health)
Source: the Mail online | Health - May 8, 2018 Category: Consumer Health News Source Type: news

The Case for Early Screening Mammography The Case for Early Screening Mammography
' Pennywise and pound foolish'screening guidelines put women under 50 at increased risk for delayed breast cancer diagnosis, say researchers.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - May 8, 2018 Category: Radiology Tags: Hematology-Oncology News Source Type: news

OncoSec to combine ImmunoPulse device with Merck ’ s immunotherapy in breast cancer trial
OncoSec Medical (NSDQ:ONCS) expanded its relationship with Merck (NYSE:MRK) today, announcing a deal to combine its ImmunoPulse IL-12 device with Merck’s anti-PD-1 therapy, Keytruda, in a Phase II trial of patients with triple negative breast cancer. The trial is slated to study the drug-device combination in patients with inoperable locally advanced or metastatic cancer who have failed at least one systemic chemotherapy or immunotherapy. Get the full story at our sister site, Drug Delivery Business News. The post OncoSec to combine ImmunoPulse device with Merck’s immunotherapy in breast cancer t...
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Pharmaceuticals Wall Street Beat Merck OncoSec Medical Source Type: news

Breast cancer survivors have increased risk of diabetes
A study, published in theJournal of Clinical Oncology, reports that women successfully treated with hormone therapy for breast cancer have a greater risk of developing diabetes. Medpage Today (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 8, 2018 Category: Endocrinology Source Type: news

Mass. imaging spending, use higher than other states
The Massachusetts Health Policy Commission has released a report that finds...Read more on AuntMinnie.comRelated Reading: MITA: MedPAC offers no new proof of imaging overuse ACR 2016: Repeat head CT not always overutilization Is imaging use poised for expansion or contraction? Study links overuse of imaging for prostate, breast cancer Geographic variations don't necessarily signify imaging overuse (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 8, 2018 Category: Radiology Source Type: news

ONC201 kills breast cancer cells in vitro by targeting mitochondria
(Rapamycin Press) 'Our work identifies a novel mechanism of ONC201 cytotoxicity that is based on the disruption of mitochondrial function, leading to ATP depletion and cell death in cancer cells that are dependent on mitochondrial respiration. Our study also suggests that cancer cells that are dependent on glycolysis will be resistant to ONC201' Dr. Stanley Lipkowitz, Chief, Women's Malignancies Branch, NCI. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

Texas A & M study links breast cancer to the body's internal clock
(Texas A&M University) For years, doctors have associated the BRCA1 and BRCA2 gene mutations with an increased risk of breast cancer. But researchers at Texas A&M University have now identified another gene that may have an impact on breast cancer --associated with the body's circadian rhythm. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

Genetic Test Criteria Often Miss Breast Cancer Risk
(MedPage Today) -- Similar cancer-linked mutations in patients who did or did not met test criteria (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 7, 2018 Category: Hematology Source Type: news

Impact of mass breast cancer screening has been overrated | Letter
It has not been shown to affect women ’s life expectancy overall, but does increase invasive interventions, saySusan Bewley, Nick RossandMargaret McCartney of HealthWatchThe announcement that thousands missed out on mammography tests caused distress to many women and their families (Report, 4 May). The implication was that they now risked premature death from cancer. In fact, as many experts have been pointing out, mass screening for breast cancer has not been shown to have any impact on women ’s life expectancy overall – but it does increase invasive interventions like mastectomy. This is why Prof Mike B...
Source: Guardian Unlimited Science - May 7, 2018 Category: Science Authors: Letters Tags: Breast cancer Health Society Cancer research Medical research Science Women Life and style UK news Jeremy Hunt Politics Source Type: news

Poor Prognosis for Interval Breast Cancer After Negative Mammo
Odds of poor prognosis after mammography with negative results higher for younger women (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 7, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Radiology, Journal, Source Type: news

Poor Prognosis for Interval Breast Cancer After Negative Mammo
MONDAY, May 7, 2018 -- The likelihood of having breast cancer with a poor prognosis is increased for cancer diagnosed after a screening mammography with negative results, according to a research letter published online May 3 in JAMA Oncology. Anne... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 7, 2018 Category: Pharmaceuticals Source Type: news

High Insurance Deductibles Lead Breast Cancer Patients to Delay Care: Study
Title: High Insurance Deductibles Lead Breast Cancer Patients to Delay Care: StudyCategory: Health NewsCreated: 5/4/2018 12:00:00 AMLast Editorial Review: 5/7/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 7, 2018 Category: Cancer & Oncology Source Type: news

ASBrS: Regular mammo screening = less-invasive treatment
Regular breast cancer screening, particularly in younger women, translates...Read more on AuntMinnie.comRelated Reading: ASBrS: No, we're not overtreating DCIS ASBrS: 50% of women under 45 at elevated breast cancer risk ASBrS: For node-positive breast cancer, radiotherapy is best ASBrS: Radiotherapy after mastectomy may not be beneficial ASBrS: RF ablation shows promise; thermography not so much (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 7, 2018 Category: Radiology Source Type: news

Breast cancer: Discovery of a protein linked to metastasis
(University of Montreal) Montreal researchers experimentally block the spread of a type of breast cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 7, 2018 Category: International Medicine & Public Health Source Type: news

Why tests can do more harm than good for some women, says DR ELLIE CANNON
On Wednesday, Health Secretary Jeremy Hunt admitted that 450,000 women aged 68 to 71 had not been invited to their final routine breast cancer scan. (Source: the Mail online | Health)
Source: the Mail online | Health - May 6, 2018 Category: Consumer Health News Source Type: news

Don't bother with catch-ups, says breast scan professor  
Women  who missed out on mammograms due to a computer error should ignore invitations for a ‘catch-up’ scan, according to an architect of the NHS breast cancer screening programme. (Source: the Mail online | Health)
Source: the Mail online | Health - May 6, 2018 Category: Consumer Health News Source Type: news

Breast cancer screening programme 'does more harm than good'
A group of doctors say any women offered catch-up appointments should 'carry on with their lives'. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 5, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Common drug may help battle aggressive breast cancer
A new study concludes that a common osteoporosis drug may help to fight basal-like breast cancer, which is an aggressive, early-onset form of the disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 5, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Did Breast Cancer Screening Error Cause Major Health Harm? Did Breast Cancer Screening Error Cause Major Health Harm?
After the IT failure that led to 450,000 older women in England missing out on breast cancer screening, calls to charity helplines soared but some medical experts say any harm to public health is likely to be limited.Medscape News UK (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 4, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Breast screening: Bosses should take blame
Helen Jarvis has been affected by the breast cancer screening error. She said there were problems with the helpline. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 4, 2018 Category: Consumer Health News Source Type: news

Breast screen error: 'People at the top need to admit to the problem'
Helen Jarvis has been affected by the breast cancer screening error. She said there were problems with the helpline. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 4, 2018 Category: Consumer Health News Source Type: news

Meta-analysis: Recurrence Rates After Lumpectomy Have Improved Meta-analysis: Recurrence Rates After Lumpectomy Have Improved
More than ever before, breast-conserving surgery is a treatment option for more breast cancer patients, say experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Endocrine-Disrupting Agents Found in Black Women's Hair Products Endocrine-Disrupting Agents Found in Black Women's Hair Products
Black women have earlier puberty, higher infertility rates, and more aggressive breast cancer. Could part of the explanation lie in hormone-disrupting chemicals in hair care products?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 4, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

HSJ Weekly Catch Up: New CQC chief, not enough beds and the breast cancer scandal
Your essential update on health for the week. (Source: HSJ)
Source: HSJ - May 4, 2018 Category: UK Health Source Type: news

Screening Mammography Lowers Breast Cancer Patients' Needs For Aggressive Treatment, Study Finds
Women in their forties without prior screening had significantly larger tumors and were much more likely to have positive lymph nodes. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 4, 2018 Category: Pharmaceuticals Authors: Elaine Schattner, Contributor Source Type: news

Screening Mammos Linked to Less Aggressive Tx If Diagnosed
FRIDAY, May 4, 2018 -- Breast cancer screening is associated with less aggressive treatment, including among women aged 40 to 49 years, according to a study presented at the annual meeting of the American Society of Breast Surgeons, held from May 2... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 4, 2018 Category: Pharmaceuticals Source Type: news

Early Intervention May Reduce Breast CA-Related Lymphedema
FRIDAY, May 4, 2018 -- For breast cancer patients undergoing treatments that are high risk for the development of breast cancer-related lymphedema (BCRL), evaluations with bioimpedance spectroscopy (BIS) allows for early detection of BCRL that is... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 4, 2018 Category: Pharmaceuticals Source Type: news

Women With Breast Cancer Delay Care When Faced With High Deductibles
When people must pay thousands of dollars before their insurance kicks in, studies show, they postpone necessary tests and treatments. (Source: NYT Health)
Source: NYT Health - May 4, 2018 Category: Consumer Health News Authors: REED ABELSON Tags: Breast Cancer Health Insurance and Managed Care Komen, Susan G, for the Cure Source Type: news

Device Might Detect Breast Cancer-Linked Swelling Sooner
Title: Device Might Detect Breast Cancer-Linked Swelling SoonerCategory: Health NewsCreated: 5/3/2018 12:00:00 AMLast Editorial Review: 5/4/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 4, 2018 Category: Cancer & Oncology Source Type: news

Breast Cancer Prognosis May Be Worse If Diagnosis Follows 'Negative' Mammogram
Title: Breast Cancer Prognosis May Be Worse If Diagnosis Follows 'Negative' MammogramCategory: Health NewsCreated: 5/3/2018 12:00:00 AMLast Editorial Review: 5/4/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 4, 2018 Category: Cancer & Oncology Source Type: news

Age, not density, predicts interval breast cancer result
A woman's age may predict whether an interval breast cancer will have a poor...Read more on AuntMinnie.comRelated Reading: Breast ultrasound traits help predict cancer prognosis Low breast density worsens cancer prognosis MRI shows promise as way to measure breast cancer prognosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 4, 2018 Category: Radiology Source Type: news

Osteoporosis drug could be used to treat aggressive form of breast cancer, researchers say
(Rockefeller University Press) Researchers in China have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer, an aggressive form of the disease that is largely untreatable. But the study, which will be published May 4 in the Journal of Experimental Medicine, reveals that the widely used osteoporosis drug zoledronic acid inhibits UGT8 and prevents the spread of basal-like breast cancer in mice, suggesting that this drug could also be used to treat the disease in humans. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 4, 2018 Category: Cancer & Oncology Source Type: news

Living With Cancer: Understanding breast cancer types
Breast cancer types: What your classification means? Once you've been diagnosed with breast cancer, your health care provider will review your pathology report and the results of any imaging tests to understand the specifics of your tumor. Determining your breast cancer type helps him or her decide which treatment options are most appropriate for you. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 4, 2018 Category: Databases & Libraries Source Type: news

Breast Cancer Prognosis May Be Worse If Diagnosis Follows 'Negative' Mammogram
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - May 4, 2018 Category: Cancer & Oncology Source Type: news

Device Might Detect Breast Cancer-Linked Swelling Sooner
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - May 4, 2018 Category: Cancer & Oncology Source Type: news